Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Patient-Specific Biomechanical Modeling of Incisional Hernias Using Artificial Intelligence and Finite Element Analysis

NCT07898449 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2026-10-14
Last updated
2026-10-27

Condition(s) studied

Incisional Hernia

Study summary

Incisional hernias are defects in the continuity of the abdominal wall that impair its mechanical function. This retrospective, single-center, non-interventional study aims to develop a patient-specific biomechanical model of the abdominal wall using artificial intelligence and finite element analysis. Anonymized computed tomography (CT) data will be analyzed to automatically identify and quantify key morphological features of the abdominal wall and incisional hernia. These features will be combined with clinical data and previously obtained experimental data on tissue mechanics to create a numerical model tailored to each patient.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older. * Patients who underwent surgery at the University Hospital of Strasbourg between January 1, 2018, and September 1, 2026. * Midline, lateral, or parastomal incisional hernia. * Prosthetic reinforcement may or may not have been used. Exclusion Criteria: * Written objection documented in the patient's medical record to the reuse of their data for scientific research. * Legal protection measure. * Minor patients. * Pregnancy.

Primary outcome measure(s)

  • Automated Identification and Quantification of Abdominal Wall and Incisional Hernia Morphological Parameters — Retrospective data from patients operated on between January 1, 2018, and September 1, 2026
    Identification and automatic quantification, using artificial intelligence, of the main morphological parameters of the abdominal wall and incisional hernia from anonymized CT scans.

Trial sites (1)

FacilityCityRegionStatus
Service de cchirurgie générale & digestive - CHU de Strasbourg, France Strasbourg France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07898449 on ClinicalTrials.gov ↗ ← All trials in France